2Suppliers
5Customers
3Debt Items
0Related Chains

Source-Backed Evidence Depth

Delcath Systems, Inc. (DCTH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships
1Distinct source URLs
10High confidence
0.878Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Delcath Systems, Inc. Suppliers

TickerNameConfidenceEvidence
MYLAN-TEORANTA MYLAN-TEORANTA 92% The Company has a License, Supply and Contract Manufacturing Agreement (as amended, the “Supply Agreement”) with Synerx Pharma, LLC and Mylan Teoranta for the supply of melphalan provided in the HEPZ…
SYNERX-PHARMA-LLC SYNERX-PHARMA-LLC 92% The Company has a License, Supply and Contract Manufacturing Agreement (as amended, the “Supply Agreement”) with Synerx Pharma, LLC and Mylan Teoranta for the supply of melphalan provided in the HEPZ…

Delcath Systems, Inc. Customers

TickerNameConfidenceEvidence
CUSTOMER-1 CUSTOMER-1 90% For the three months ended and as of March 31, 2026 % of Revenue % of Accounts Receivable Customer 1 15.9 % 10.7 %
CUSTOMER-2 CUSTOMER-2 90% For the three months ended and as of March 31, 2026 % of Revenue % of Accounts Receivable Customer 2 10.6 % 9.3 %
CUSTOMER-3 CUSTOMER-3 90% For the three months ended and as of March 31, 2025 % of Revenue % of Accounts Receivable Customer 3 10.3 % 6.7 %
CUSTOMER-4 CUSTOMER-4 90% For the three months ended and as of March 31, 2025 % of Revenue % of Accounts Receivable Customer 4 9.4 % 10.8 %
SYNERX-PHARMA-LLC SYNERX-PHARMA-LLC 62% greement (as amended, the “Supply Agreement”) with Synerx Pharma, LLC and Mylan Teoranta for the supply of melphalan provided in the HEPZATO KIT. An amendment to the Supply Agreement was entered into…

Delcath Systems, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
DCTH-DEBT-9043 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-12-31.
DCTH-DEBT-9042 Warrants outstanding: 34072 90% xbrl warrant detail from xbrl 2025-12-31.
DCTH-DEBT Debt stack $907,000 90% Market cache reports total debt of $907,000.

Delcath Systems, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Delcath Systems, Inc..

Delcath Systems, Inc. Ownership

HolderNameConfidenceEvidence
DCTH-OWNER-ROSALIND-ADVISORS-INC Rosalind Advisors, Inc. 90% 13F overlay lists Rosalind Advisors, Inc. as top holder; 123 tracked holders.

Delcath Systems, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
🔐
DCTH
Unlock DCTH Supply Chain Data
Verified relationships include:
MYLAN-TEORANTAMYLAN-TEORANTASupplier92%
SYNERX-PHARMA-LLCSYNERX-PHARMA-LLCSupplier92%
CUSTOMER-1CUSTOMER-1Customer90%
CUSTOMER-2CUSTOMER-2Customer90%
+7 more relationships locked
Subscribe — View plans →